Study to Evaluate the Effect of Aficamten Administration on QT/QTc Interval

NCT05924815 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Aficamten
DRUG: Aficamten-matching Placebo
DRUG: Moxifloxacin

Sponsor

Cytokinetics